Exosens (EXOSF) Financial Statements
Exosens Financial Overview
Exosens's market cap is currently $3.24B. The company's EPS TTM is $0.59; its P/E ratio is 93.73; and it has a dividend yield of 0.47%. Exosens has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 468.20M | $ 394.10M | $ 318.80M | $ 200.75M | $ 166.17M |
| Gross Profit | $ 102.20M | $ 225.60M | $ 176.81M | $ 113.95M | $ 100.03M |
| Operating Income | $ 102.20M | $ 76.90M | $ 55.28M | $ 30.45M | $ 31.95M |
| EBITDA | $ 142.10M | $ 108.61M | $ 77.84M | $ 51.25M | $ -101.18M |
| Net Income | $ 42.70M | $ 30.70M | $ 17.14M | $ 11.21M | $ -148.97M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 101.90M | $ 150.20M | $ 15.53M | $ 29.00M | $ 15.93M |
| Total Assets | $ 878.90M | $ 817.00M | $ 656.41M | $ 529.25M | $ 460.52M |
| Total Debt | $ 280.00M | $ 261.28M | $ 311.77M | $ 255.28M | $ 208.11M |
| Net Debt | $ 211.40M | $ 144.08M | $ 296.31M | $ 220.01M | $ 192.19M |
| Total Liabilities | $ 433.30M | $ 404.40M | $ 452.35M | $ 346.20M | $ 288.41M |
| Stockholders' Equity | $ 445.70M | $ 412.60M | $ 204.06M | $ 183.05M | $ 172.11M |
| Cash Flow | |||||
| Free Cash Flow | $ 48.50M | $ 96.20M | $ 19.53M | $ 25.69M | $ 23.07M |
| Operating Cash Flow | $ 98.60M | $ 96.20M | $ 50.46M | $ 47.48M | $ 42.66M |
| Investing Cash Flow | $ -121.20M | $ -72.70M | $ -99.64M | $ -55.48M | $ -21.26M |
| Financing Cash Flow | $ -16.40M | $ 76.30M | $ 35.49M | $ 20.26M | $ -36.83M |
Currency in EUR
